Lina_S

About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 417 blog entries.

Comorbidity in older adults with cancer

2021-07-29T22:38:01+02:00

Grant R. Williams, Amy Mackenzie, Allison Magnuson, Rebecca Olin, Andrew Chapman, Supriya Mohile, Heather Allore, Mark R. Somerfield, Valerie Targia, Martine Extermann, Harvey Jay Cohen, Arti Hurria, Holly Holmes. Journal of Geriatric Oncology, July 2016 Volume 7, Issue 4, Pages 249–257

Comorbidity in older adults with cancer2021-07-29T22:38:01+02:00

JGO ARTICLE OF THE MONTH – A review and assessment of currently available data of the EGFR antibodies in elderly patients with metastatic colorectal cancer

2021-07-29T22:38:01+02:00

JGO article of the month (most requested article in March 2016) Gerardo Rosati, Giuseppe Aprile, Giovanni Gerardo Cardellino, Antonio Avallone. Journal of Geriatric Oncology Vol. 7, Issue 2, p134–141

JGO ARTICLE OF THE MONTH – A review and assessment of currently available data of the EGFR antibodies in elderly patients with metastatic colorectal cancer2021-07-29T22:38:01+02:00

JGO ARTICLE OF THE MONTH – Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis

2021-07-29T22:38:01+02:00

JGO article of the month (most requested article in December 2015) Chia-Lin Hsu, Jen-Hau Chen, Kuan-Yu Chen, Jin-Yuan Shih, James Chih-Hsin Yang, Chong-Jen Yu, Pan-Chyr Yang. Journal of Geriatric Oncology, Vol. 6, Issue 1

JGO ARTICLE OF THE MONTH – Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis2021-07-29T22:38:01+02:00

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial

2021-07-29T22:38:01+02:00

Hulin C, Belch A, Shustik C, Petrucci MT, Dührsen U, Lu J, Song K, Rodon P, Pégourié B, Garderet L, Hunter H, Azais I, Eek R, Gisslinger H, Macro M, Dakhil S, Goncalves C, LeBlanc R, Romeril K, Royer B, Doyen C, Leleu X, Offner F, Leupin N, Houck V, Chen G, Ervin-Haynes A, Dimopoulos MA, Facon T. J Clin Oncol. 2016 Jun 20. pii: JCO667295. [Epub ahead of print]

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial2021-07-29T22:38:01+02:00

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials

2021-07-29T22:38:01+02:00

Hershman DL, Till C, Wright JD, Awad D, Ramsey SD, Barlow WE, Minasian LM, Unger J. J Clin Oncol. 2016 Jun 20. pii: JCO662346. [Epub ahead of print]

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials2021-07-29T22:38:01+02:00

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma

2021-07-29T22:38:01+02:00

Magarotto V, Bringhen S, Offidani M, Benevolo G, Patriarca F, Mina R, Falcone AP, De Paoli L, Pietrantuono G, Gentili S, Musolino C, Giuliani N, Bernardini A, Conticello C, Pulini S, Ciccone G, Maisnar V, Ruggeri M, Zambello R, Guglielmelli T, Ledda A, Liberati AM, Montefusco V, Hajek R, Boccadoro M, Palumbo A. Blood. 2016 Mar 3;127(9):1102-8. doi: 10.1182/blood-2015-08-662627. Epub 2016 Jan 4.

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma2021-07-29T22:38:01+02:00
Go to Top